Localization and altered expression of nucleophosmin in the nuclear matrix during the differentiation of human hepatocarcinoma SMMC-7721 cells induced by HMBA

Cancer Investigation

Volumn 28, Issue 10, 2010, Pages 1004-1012

  Li, Qi Fu ^a   Tang, Jian ^a   Liu, Qing Rong ^b   Shi, Song Lin ^a   Chen, Xiang Feng ^a  

^a XIAMEN UNIVERSITY   (China)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cell differentiation; Hepatocarcinoma cell; Nuclear matrix; Nucleophosmin

Indexed keywords

HEXAMETHYLENEBISACETAMIDE; MYC PROTEIN; NUCLEAR MATRIX PROTEIN; NUCLEOPHOSMIN; PROTEIN C FOS; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ARTICLE; CARCINOMA CELL; CELL DEDIFFERENTIATION; CELL NUCLEUS MATRIX; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOGOLD ELECTRON MICROSCOPY; LIVER CELL CARCINOMA; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEOMICS; TUMOR SUPPRESSOR GENE;

ACETAMIDES; ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL LINE, TUMOR; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MICROSCOPY, CONFOCAL; MICROSCOPY, ELECTRON, TRANSMISSION; MICROSCOPY, FLUORESCENCE; NUCLEAR MATRIX; NUCLEOPLASMINS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 78649302697     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357900902918452     Document Type: Article

References (24)

1. Okuda, M. The role of nucleophosmin in centrosome duplication. Oncogene 2002, 21 (40), 6170-6174.
2. Olson, M. O. Sensing cellular stress: another new function for the nucleolus? Sci STKE 2004, 2004 (224): pe10.
3. Ye, K. Nucleophosmin/B23, a multifunctional protein that can regulate apoptosis. Cancer Biol Ther 2005, 4 (9), 918-923.
4. Frehlick, L. J.; Eirin-Lopez, J. M.; Ausio, J. New insights into the nucleophosmin/nucleoplasmin family of nuclear chaperones. Bioessays 2007, 29 (1), 49-59.
5. Naoe, T.; Suzuki, T.; Kiyoi, H.; Urano, T. Nucleophosmin: a versatile molecule associated with hematological malignancies. Cancer Sci 2006, 97 (10), 963-969.
6. Lim, M. J.; Wang, X. W. Nucleophosmin and human cancer. Cancer Detect Prev 2006, 30 (6), 481-490.
7. Alsayed, Y.; Uddin, S.; Mahmud, N.; Lekmine, F.; Kalvakolanu, D. V.; Minucci, S.; Bokoch, G.; Platanias, L. C. Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. J Biol Chem 2001, 276 (6), 4012-4019.
8. Yun, J. P.; Chew, E. C.; Liew, C. T.; Chan, J. Y.; Jin, M. L.; Ding, M. X.; Fai, Y. H.; Li, H. K.; Liang, X. M.; Wu, Q. L. Nucleophosmin/B23 is a proliferate shuttle protein associated with nuclear matrix. J Biol Chem 2003, 90 (6), 1140-1148.
9. Subong, E. N.; Shue, M. J.; Epstein, J. I.; Briggman, J. V.; Chan, P. K.; Partin, A. W. Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23. Prostate 1999, 39 (4), 298-304.
10. Li, Q. F. Effect of retinoic acid on the changes of nuclear matrix in termediate filament system in gastric carcinoma cells. World J Gastroenterol 1999, 5 (5), 417-420.
11. Michishita, E.; Kurahashi, T.; Suzuki, T.; Fukuda, M.; Fujii, M.; Hirano, H.; Ayusawa, D. Changes in nuclear matrix proteins during the senescence-like phenomenon induced by 5-chlorodeoxyuridine in HeLa cells. Exp Gerontol 2002, 37 (7), 885-890.
12. Alberti, I.; Barboro, P.; Barbesino, M.; Sanna, P.; Pisciotta, L.; Parodi, S.; Nicolo, G.; Boccardo, F.; Galli, S.; Patrone, E.; Balbi, C. Changes in the expression of cytokeratins and nuclear matrix proteins are correlated with the level of differentiation in human prostate cancer. J Biol Chem 2000, 79 (3), 471-485.
13. Jin, M. L.; Zhang, P.; Ding, M. X.; Yun, J. P.; Chen, P. F.; Chen, Y. H.; Chew, Y. Q. Altered expression of nuclear matrix proteins in etoposide induced apoptosis in HL-60 cells. Cell Res 2001, 11 (2), 125-134.
14. Grisendi, S.; Mecucci, C.; Falini, B.; Pandolfi, P. P. Nucleophosmin and cancer. Nat Rev Cancer 2006, 6 (7), 493-505.
15. Yung, B. Y. c-Myc-mediated expression of nucleophosmin/B23 decreases during retinoic acid-induced differentiation of human leukemia HL-60 cells. FEBS Lett 2004, 578 (3), 211-216.
16. Zeller, K. I.; Haggerty, T. J.; Barrett, J. F.; Guo, Q.; Wonsey, D. R.; Dang, C. V. Characterization of nucleophosmin (B23) as a Myc target by scanning chromatin immunoprecipitation. J Biol Chem 2001, 276 (51), 48285-48291.
17. Lambert, B.; Buckle, M. Characterisation of the interface between nucleophosmin (NPM) and p53: potential role in p53 stabilisation. FEBS Lett 2006, 580 (1), 345-350.
18. Kurki, S.; Peltonen, K.; Latonen, L.; Kiviharju, T. M.; Ojala, P. M.; Meek, D.; Laiho, M. Nucleolar protein NPM interacts with HDM2 and protects tumor suppressor protein p53 from HDM2-mediated degradation. Cancer Cell 2004, 5 (5), 465-475.
19. Bertwistle, D.; Sugimoto, M.; Sherr, C. J. Physical and functional interactions of the Arf tumor suppressor protein with nucleophosmin/B23. Mol Cell Biol 2004, 24 (3), 985-996.
20. Lin, C. Y.; Liang, Y. C.; Yung, B. Y. Nucleophosmin/B23 regulates transcriptional activation of E2F1 via modulating the promoter binding of NF-kappaB, E2F1 and pRB. Cell Signal 2006, 18 (11), 2041-2048.
21. Brooks, C. L.; Gu, W. Dynamics in the p53-Mdm2 ubiquitination pathway. Cell Cycle 2004, 3 (7), 895-899.
22. Chan, P. K.; Bloom, D. A.; Hoang, T. T. The N-terminal half of NPM dissociates from nucleoli of HeLa cells after anticancer drug treatments. Biochem Biophys Res Commun 1999, 264 (1), 305-309.
23. Liu, Q. R.; Chan, P. K. Formation of nucleophosmin/B23 oligomers requires both the amino- and the carboxyl-terminal domains of the protein. Eur J Biochem 1991, 200 (3), 715-721.
24. Qi, W.; Shakalya, K.; Stejskal, A.; Goldman, A.; Beeck, S.; Cooke, L.; Mahadevan, D. NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells. Oncogene 2008, 27 (30), 4210-4220.